Fig. 3From: Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysisCost-effectiveness acceptability curve a without renal impact and b with renal impact. ADV adefovir dipivoxil, BSC best supportive care, ETV entecavir, LAM lamivudine, LDT telbivudine, TDF tenofovirBack to article page